Assessing the uncertainty around the survival estimates used in multi-criteria decision anlaysis (MCDA). the alectinib case in Argentina using the Latin America federation of pharmaceutical industry (FIFARMA) framework.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Panos Orfanos, Claudio Martin, María De San Martín, Juan Pablo Denamiel, Francisco Tellechea, Lucas Najun Dubos, Joice Valentim
Institutions: F. Hoffmann-La Roche AG, Instituto Alexander Fleming
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2890695404